Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2017

31.07.2017 | Gynecologic Oncology

Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment

verfasst von: Salih Taşkın, Yavuz Emre Şükür, Bulut Varlı, Kazibe Koyuncu, Mehmet Murat Seval, Can Ateş, Selcen Yüksel, Mete Güngör, Fırat Ortaç

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the clinical and pathological risk factors for lymph node metastasis (LNM) in patients with endometrial cancer and to create a nomogram to predict LNM in patients without surgical staging.

Methods

All patients with endometrial adenocarcinoma who were treated surgically at a university based gynecologic oncology clinic between January 2011 and December 2014 were recruited. Women with endometrial adenocarcinoma who were surgically staged including lymphadenectomy were included in the study. Data regarding clinical and pathological risk factors were recorded. The histopathologic slides from the staging surgeries were re-evaluated microscopically by a gynecologic pathologist for all parameters along with lymphovascular space invasion (LVSI).

Results

A total of 279 patients with endometrial cancer were analyzed. Among those, 31 (11.1%) had lymph node metastasis. According to the univariate analyses, elevated CA 125 (>35 U/mL), LVSI, myometrial invasion ≥50%, grade 3 disease, non-endometrioid type, and cervical stromal involvement were significantly associated with LNM. The multivariate logistic regression analysis showed that LVSI, non-endometrioid type, elevated CA 125, and cervical stromal involvement increased the risk of LNM. However, myometrial invasion and grade did not significantly affect the risk of LNM. A nomogram to predict LNM was constructed using these factors (concordance index 0.92).

Conclusions

LVSI is the most important predictor for LNM. The present nomogram can be useful to decide if adjuvant therapy is required for patients who undergo simple hysterectomy for a benign etiology and incidentally diagnosed with endometrial cancer by pathological evaluation.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
2.
Zurück zum Zitat Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104CrossRefPubMed Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103–104CrossRefPubMed
3.
Zurück zum Zitat Colombo N, Creutzberg C, Amant F et al (2016) ESMO–ESGO–ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 26:2–30CrossRefPubMed Colombo N, Creutzberg C, Amant F et al (2016) ESMO–ESGO–ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 26:2–30CrossRefPubMed
4.
Zurück zum Zitat Frost JA, Webster KE, Bryant A et al (2015) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 9:CD007585 Frost JA, Webster KE, Bryant A et al (2015) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 9:CD007585
5.
Zurück zum Zitat Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716CrossRefPubMed Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716CrossRefPubMed
6.
Zurück zum Zitat Creutzberg CL, van Putten WLJ, Koper PCM et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Postoperative radiation therapy in endometrial carcinoma. Lancet 355:1404–1411CrossRefPubMed Creutzberg CL, van Putten WLJ, Koper PCM et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Postoperative radiation therapy in endometrial carcinoma. Lancet 355:1404–1411CrossRefPubMed
7.
Zurück zum Zitat Hahn HS, Chun YK, Kwon YI et al (2010) Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 150:80–83CrossRefPubMed Hahn HS, Chun YK, Kwon YI et al (2010) Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol 150:80–83CrossRefPubMed
8.
Zurück zum Zitat Solmaz U, Mat E, Dereli M et al (2015) Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer. Aust N Z J Obstet Gynaecol 55:81–86CrossRefPubMed Solmaz U, Mat E, Dereli M et al (2015) Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer. Aust N Z J Obstet Gynaecol 55:81–86CrossRefPubMed
9.
Zurück zum Zitat Solmaz U, Mat E, Dereli ML et al (2015) Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer. Eur J Obstet Gynecol Reprod Biol 186:63–67CrossRefPubMed Solmaz U, Mat E, Dereli ML et al (2015) Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer. Eur J Obstet Gynecol Reprod Biol 186:63–67CrossRefPubMed
10.
Zurück zum Zitat Hahn HS, Lee IH, Kim TJ et al (2013) Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol 53:293–297CrossRefPubMed Hahn HS, Lee IH, Kim TJ et al (2013) Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol 53:293–297CrossRefPubMed
11.
Zurück zum Zitat Pollom EL, Conklin CM, von Eyben R et al (2015) Nomogram to predict risk of lymph node metastases in patients with endometrioid endometrial cancer. Int J Gynecol Pathol. doi:10.1097/PGP.0000000000000246 Pollom EL, Conklin CM, von Eyben R et al (2015) Nomogram to predict risk of lymph node metastases in patients with endometrioid endometrial cancer. Int J Gynecol Pathol. doi:10.​1097/​PGP.​0000000000000246​
12.
Zurück zum Zitat Akbayir O, Corbacioglu A, Goksedef BP et al (2012) The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium. Gynecol Oncol 125:400–403CrossRefPubMed Akbayir O, Corbacioglu A, Goksedef BP et al (2012) The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium. Gynecol Oncol 125:400–403CrossRefPubMed
13.
Zurück zum Zitat Abu-Rustum NR, Iasonos A, Zhou Q et al (2008) Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol 198:457.e1–457.e5CrossRef Abu-Rustum NR, Iasonos A, Zhou Q et al (2008) Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol 198:457.e1–457.e5CrossRef
14.
Zurück zum Zitat Kitchener H, Swart AM, Qian Q et al (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136CrossRefPubMed Kitchener H, Swart AM, Qian Q et al (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136CrossRefPubMed
15.
Zurück zum Zitat Cragun JM, Havrilesky LJ, Calingaert B et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23:3668–3675CrossRefPubMed Cragun JM, Havrilesky LJ, Calingaert B et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23:3668–3675CrossRefPubMed
16.
Zurück zum Zitat Mariani A, Webb MJ, Keeney GL et al (2002) Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 84:437–442CrossRefPubMed Mariani A, Webb MJ, Keeney GL et al (2002) Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 84:437–442CrossRefPubMed
17.
Zurück zum Zitat Cohn DE, Horowitz NS, Mutch DG et al (2002) Should the presence of lymphovascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 87:243–246CrossRefPubMed Cohn DE, Horowitz NS, Mutch DG et al (2002) Should the presence of lymphovascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 87:243–246CrossRefPubMed
18.
Zurück zum Zitat Ambros RA, Kurman RJ (1992) Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 69:1424–1431CrossRefPubMed Ambros RA, Kurman RJ (1992) Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 69:1424–1431CrossRefPubMed
19.
Zurück zum Zitat Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744–751CrossRefPubMed Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744–751CrossRefPubMed
20.
Zurück zum Zitat Weber SK, Sauerwald A, Pölcher M et al (2012) Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer. Int J Gynecol Cancer 22:1442–1448CrossRefPubMed Weber SK, Sauerwald A, Pölcher M et al (2012) Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer. Int J Gynecol Cancer 22:1442–1448CrossRefPubMed
21.
Zurück zum Zitat Alexander-Sefre F, Singh N, Ayhan A et al (2003) Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry. J Clin Pathol 56:786–788CrossRefPubMedPubMedCentral Alexander-Sefre F, Singh N, Ayhan A et al (2003) Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry. J Clin Pathol 56:786–788CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Turan T, Hizli D, Sarici S et al (2011) Is it possible to predict para-aortic lymph node metastasis in endometrial cancer? Eur J Obstet Gynecol Reprod Biol 158:274–279CrossRefPubMed Turan T, Hizli D, Sarici S et al (2011) Is it possible to predict para-aortic lymph node metastasis in endometrial cancer? Eur J Obstet Gynecol Reprod Biol 158:274–279CrossRefPubMed
23.
24.
Zurück zum Zitat Karabagli P, Ugras S, Yılmaz BS et al (2015) The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas. Arch Gynecol Obstet 292:391–397CrossRefPubMed Karabagli P, Ugras S, Yılmaz BS et al (2015) The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas. Arch Gynecol Obstet 292:391–397CrossRefPubMed
25.
Zurück zum Zitat Celik C, Ozdemir S, Esen H et al (2010) The clinical value of preoperative and intraoperative assessments in the management of endometrial cancer. Int J Gynecol Cancer 20:358–362CrossRefPubMed Celik C, Ozdemir S, Esen H et al (2010) The clinical value of preoperative and intraoperative assessments in the management of endometrial cancer. Int J Gynecol Cancer 20:358–362CrossRefPubMed
26.
27.
28.
Zurück zum Zitat Dotters DJ (2000) Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 182:1328–1334CrossRefPubMed Dotters DJ (2000) Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 182:1328–1334CrossRefPubMed
29.
Zurück zum Zitat Nicklin J, Janda M, Gebski V et al (2012) The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer. Int J Cancer 131:885–890CrossRefPubMed Nicklin J, Janda M, Gebski V et al (2012) The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer. Int J Cancer 131:885–890CrossRefPubMed
30.
Zurück zum Zitat Santala M, Talvensaari-Mattila A, Kauppila A (2003) Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Anticancer Res 23:3097–3103PubMed Santala M, Talvensaari-Mattila A, Kauppila A (2003) Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Anticancer Res 23:3097–3103PubMed
31.
Zurück zum Zitat AlHilli MM, Podratz KC, Dowdy SC et al (2013) Risk-scoring system fort he individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol 131:103–108CrossRefPubMed AlHilli MM, Podratz KC, Dowdy SC et al (2013) Risk-scoring system fort he individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol 131:103–108CrossRefPubMed
32.
Zurück zum Zitat Mahdi H, Munkarah AR, Ali-Fehmi R et al (2015) Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer. Arch Gynecol Obstet 292:183–190CrossRefPubMed Mahdi H, Munkarah AR, Ali-Fehmi R et al (2015) Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer. Arch Gynecol Obstet 292:183–190CrossRefPubMed
33.
Zurück zum Zitat Gilani S, Anderson I, Fathallah L et al (2014) Factors predicting nodal metastasis in endometrial cancer. Arch Gynecol Obstet 290:1187–1193CrossRefPubMed Gilani S, Anderson I, Fathallah L et al (2014) Factors predicting nodal metastasis in endometrial cancer. Arch Gynecol Obstet 290:1187–1193CrossRefPubMed
34.
Zurück zum Zitat Göksedef BP, Akbayır Ö, Çorbacıoğlu A et al (2012) Comparison of preoperative endometrial biopsy grade and final pathologic diagnosis in patients with endometrioid endometrial cancer. J Turk Ger Gynecol Assoc 13:106–110CrossRefPubMedPubMedCentral Göksedef BP, Akbayır Ö, Çorbacıoğlu A et al (2012) Comparison of preoperative endometrial biopsy grade and final pathologic diagnosis in patients with endometrioid endometrial cancer. J Turk Ger Gynecol Assoc 13:106–110CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Karalok A, Ureyen I, Reis Y et al (2014) Prediction of staging with preoperative parameters and frozen/section in patients with a preoperative diagnosis of grade 1 endometrioid tumor in endometrial cancer. J Turk Ger Gynecol Assoc 15:41–48CrossRefPubMedPubMedCentral Karalok A, Ureyen I, Reis Y et al (2014) Prediction of staging with preoperative parameters and frozen/section in patients with a preoperative diagnosis of grade 1 endometrioid tumor in endometrial cancer. J Turk Ger Gynecol Assoc 15:41–48CrossRefPubMedPubMedCentral
Metadaten
Titel
Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment
verfasst von
Salih Taşkın
Yavuz Emre Şükür
Bulut Varlı
Kazibe Koyuncu
Mehmet Murat Seval
Can Ateş
Selcen Yüksel
Mete Güngör
Fırat Ortaç
Publikationsdatum
31.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4477-7

Weitere Artikel der Ausgabe 4/2017

Archives of Gynecology and Obstetrics 4/2017 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.